VIV Europe 2010: The Best Of A Turbulent Situation
NETHERLANDS - VIV Europe 2010 was a remarkable success despite air travel disruptions, with more than 10,000 visitors from 96 countries and 85 per cent of exhibitors making it to the event in Utrecht last month.

Intervet/Schering-Plough Opens New Vaccine Plant
NETHERLANDS - Intervet/Schering-Plough Animal Health announces that it will open today a state-of-the-art production center for veterinary vaccines against bacterial infections.

VIV Europe Takes Place as Scheduled
NETHERLANDS - As of Saturday 17 April, 17:00 hours: VIV Europe will take place as planned in Utrecht on 20 to 22 April.

VIV Europe Will Welcome Global Animal Industry
NETHERLANDS - VIV Europe is about to open its doors for the international animal protein industry. VIV Europe 2010 takes place in Utrecht on 20 to 22 April.

Online Matchmaking With Suppliers From VNU
NETHERLANDS - With the launch of Animal Protein.net, VNU Exhibitions has introduced online match-making for the worldwide markets for animal production and processing.

First Feed Tech Pavilion At VIV Europe 2010
NETHERLANDS - This year for the first time, market leaders of the Feed Technology Industry (machinery and equipment) will be present at VIV Europe 2010 in Utrecht on 20 to 22 April.

VIV Europe 2010 Returns to its Roots in Utrecht
NETHERLANDS - VIV Europe 2010 will take place on 20 to 22 April 2010 in the Jaarbeurs at Utrecht in the Netherlands.

Inspiring International Innovations at VIV Europe 2010
NETHERLANDS - VIV Europe 2010 will be packed with inspiring international innovations for future farming, says the show organiser.

Bluetongue Vaccine Release Outlines Strength of Intervet/SPAH Combination
NETHERLANDS - Intervet/Schering-Plough Animal Health has released the first batch of Bovilis BTV8 vaccine against bluetongue to supply in Northern Europe.

Intervet Has Developed Bluetongue Vaccine
THE NETHERLANDS – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and cattle. The vaccine has been taken into production now. Intervet is aiming to...

Intervet bought by Schering-Plough
NETHERLANDS - American based company Schering-Plough has announced it is to acquire the Dutch veterinary company Intervet as part of its buy out of Organon BioSciences, the pharmaceutical division of chemical company Akzo Nobel.